-+ 0.00%
-+ 0.00%
-+ 0.00%

*Dogwood Therapeutics: Halneuron Phase 2b Trial in Chemotherapy Induced Neuropathy on Track for Top-Line Results in Fall 2026, 217 Patients Enrolled >DWTX

Dow Jones·08/13/2026 12:32:00

Please log in to view news